Hemab Therapeutics Holdings, Inc. (COAG)

NASDAQ: COAG · Real-Time Price · USD

41.45

+1.03 (2.55%)

At close: Oct 30, 2026, 4:00 PM EST

41.45

0.00 (0.00%)

Pre-market: Nov 2, 2026, 8:23 AM EST

COAG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,936	-	-
Market Cap Growth	-	-	-
Enterprise Value	1,480	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.00	0.01	0.02
Net Debt / Equity Ratio	-1.00	-1.00	-0.98
Net Debt / EBITDA Ratio	5.25	2.64	1.72
Net Debt / FCF Ratio	5.89	3.00	1.88
Quick Ratio	35.48	17.62	13.45
Current Ratio	35.85	18.03	13.95
Return on Equity (ROE)	-	-46.99%	-
Return on Assets (ROA)	-	-30.11%	-
Return on Capital Employed (ROCE)	-19.20%	-38.10%	-56.20%

SEC Filings: 10-K · 10-Q